Truist Securities Maintains Buy on HCA Healthcare, Lowers Price Target to $495

Benzinga Newsdesk www.benzinga.com Negative 48.6%

Neg 48.6% Neu 0% Pos 0%

Truist Securities analyst David Macdonald maintains HCA Healthcare (NYSE:HCA) with a Buy and lowers the price target from $535 to $495.